Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
CING
#4240
Cingulate Inc. Common Stock
5.349
0
USD
-0.02%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
-0.02%
Changement Mensuel
-46.02%
Evolution sur 6 mois
-13.17%
Changement Annuel
-13.17%
Clôture Précédente
5.350
0
Open
5.380
0
Bid
Ask
Low
5.310
0
High
5.400
0
Volume
37
Marchés
Actions des Marchés US
Soins de Santé
CING
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
47.12 K
47.12 K
417.54 K
3.77 M
11.63 M
—
Valuation ratios
Enterprise value
15.85 M
12.01 M
36.21 M
11.34 M
46.96 M
102.57 M
Price to earnings ratio
—
-0.65
-0.26
-0.48
-0.98
5.46
Price to sales ratio
—
—
—
—
-10.12
—
Price to cash flow ratio
—
-0.73
-0.4
-0.41
-1.27
-2.98
Price to book ratio
—
2.97
-0.89
1.01
8.74
9.72
Enterprise value to EBITDA ratio
—
—
—
—
-3.84
—
Profitability ratios
Return on assets %
-0.9
-1.55
-6.74
-1.05
-1.49
-1.77
Return on equity %
-0.99
-4.55
3.43
-2.09
-8.95
-6.12
Return on invested capital %
-1 496.72
-971.12
-1 199.49
-1 123.26
-1 103.5
-1 119.32
Gross margin %
—
—
—
—
100
—
Operating margin %
—
—
—
—
920.04
—
EBITDA margin %
—
—
—
—
580.03
—
Net margin %
—
—
—
—
1 035.95
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
16.05
1.12
0.06
2.55
1.16
5.82
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
-0.14
—
Solvency ratios
Debt to assets ratio
0.05
0.51
0.74
0.33
0.49
1.58
Debt to equity ratio
0.05
1.5
-0.38
0.67
2.97
5.67
Long term debt to total assets ratio
0
0.44
0.6
0.33
0.49
1.58
Long term debt to total equity ratio
0
1.29
-0.31
0.67
2.97
5.67
Per share metrics
Operating cash flow per share
—
-337.05
-199.3
-12.1
-3.41
-3.85
EBIT per share
—
—
—
—
-2.6
—
EBITDA per share
—
—
—
—
-2.49
—
Total debt per share
—
123.69
34.32
3.26
1.47
4.61
Cash per share
—
113.67
0.69
8.01
2.17
7.93
Net current asset value per share
—
167
7.67
8.3
2.38
8.95
Tangible book value per share
—
82.38
-91.06
4.89
0.5
4.02
Working capital per share
—
18.18
-127.89
5.04
0.34
2.76
Book value per share
—
82.38
-91.06
4.89
0.5
4.02
Nouvelles
Qu'est-ce qui se passe avec l'action de Cingulate aujourd'hui ? | Benzinga France
Cingulate augmente sa limite d’offre sur le marché à 31,9 millions €
Cingulate increases at-the-market offering limit to $31.9 million
Cingulate rétablit Shane Schaffer comme PDG et actualise ses conditions d’emploi
Cingulate reinstates Shane Schaffer as CEO, updates employment terms
Cingulate appoints new CCO, secures $6 million financing
Cingulate’s ADHD drug meets primary endpoints in phase 3 trial
FDA accepts Cingulate’s ADHD drug application, sets May 2026 target date
Cingulate conclut un accord de fabrication avec Bend Bio Sciences pour son médicament contre le TDAH
Cingulate secures manufacturing deal with Bend Bio Sciences for ADHD drug
Cingulate issues shares to lender in series of unregistered transactions
Cingulate appoints John A. Roberts as executive chairman, CEO placed on leave